The first half of 2024 has been an active year for M&A’s in the life sciences industry. The overall data reflects significant quarterly fluctuations in the total value and count of M&A deals within the life sciences sector from 2022 to mid-2024, highlighting shifting market priorities and potential external influences such as regulatory changes or macroeconomic factors.

For detailed information and statistics on the latest M&A activity in the biotechnology and digital health sectors, read the Life Sciences M&A Report. Published biannually by Venture Valuation, the report is based on comprehensive data sourced from Biotechgate.

Read the Life Sciences M&A Report covering the first half of 2024